{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP02862",
    "Peptide Name": "CaLL (Lys-rich; synthetic AMPs20, cecropin + LL-37 hybrid peptide, UCLL1)",
    "Source": "hybrid peptide, combined natural fragments, designed, man-made sequences",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "KWKLFKKIFKRIVQRIKDFLR",
    "Sequence Length": 21,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 9,
    "Boman Index": 2.49,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "47%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "APD analysis reveals that the sequence of this peptide shows 60.7% similarity toHuman KS-27 (LL-37 derived).  N-terminal cecropin + the LL-37 core peptide.Activity: Active against B. anthracis spores (MIC 7.8 ug/mL), B. anthracis vegetative (MIC 31.3 ug/mL), and gram- B. cepacia (MIC 31.3 ug/mL). Updated 7/2021",
    "Author": "Fox MA, Thwaite JE, Ulaeto DO, Atkins TP, Atkins HS.",
    "Reference": "Peptides. 2012 Feb;33(2):197-205. doi: 10.1016/j.peptides.2012.01.013.PubMed",
    "Title": "Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II."
  },
  "3D Structure": []
}